REFEREED ARTICLES

1. Zehr KJ, Herskowitz A, Lee PC, Poston RS, Gillinov AM, Baumgartner WA. Neutrophil adhesion inhibition prolongs survival of cardiac allografts with hyperacute rejection. J Heart Lung Transplant 1993;12:837-845.

2. Zehr KJ, Lee PC, Poston RS, Gillinov AM, Hruban RH, Cameron DE. Protection of the internal mammary artery pedicle with polytetrafluoroethylene membrane. J Cardiac Surg 1993;8:650-655.

3. Zehr KJ, Herskowitz A, Lee PC, Kumar P, Gillinov AM, Baumgartner WA. Neutrophil adhesion and complement inhibition prolongs survival of cardiac xenografts in discordant species. Transplantation 1994;57:900-906.

4. Zehr KJ, Lee PC, Poston RS, Gillinov AM, Greene PS, Cameron DE. Two decades of coronary artery bypass graft surgery in young adults. Circulation 1994;90:II133-139.

5. Zehr KJ, Poston RS, Lee PC, Uthoff K, Kumar P, Cho PW, Gillinov AM, Redmond JM, Winkelstein JA, Herskowitz A. Platelet activating factor inhibition reduces lung injury after cardiopulmonary bypass. Ann Thorac Surg 1995;59:328-335.

6. Uthoff K, Zehr KJ, Lee PC, Low RA, Baumgartner WA, Cameron DE, Stuart RS. Neutrophil modulation results in improved pulmonary function after 12 and 24 hours of preservation. Ann Thorac Surg 1995;59:7-13.

7. Lee PC, Salyapongse AN, Bragdon GA, Shears LL, Watkins SC, Edington HDJ, Billiar TR. Impaired wound healing and angiogenesis in eNOS-deficient mice. Am J Physiol 1999;277:H1600-1608.

8. Lee PC, Rhee RY, Gordon RY, Fung JJ, Webster MW. Management of splenic artery aneurysms: the significance of portal and essential hypertension. J Am Coll Surg 1999;189:483-490.

9. Lee PC, Kibbe MR, Stolz DB, Gleixner SL, Watkins SC, Griffith BP, Billiar TR, Shears LL. Nitric oxide mediates growth factor-stimulated angiogenesis. Surgical Forum 1999;50:469-471.

10. Lee PC, Wang ZL, Qian S, Watkins SC, Lizonova A, Kovesdi I, Tzeng E, Simmons RL, Billiar TR, Shears LL. Endothelial nitric oxide synthase protects aortic allografts from the development of transplant arteriosclerosis. Transplantation 2000;69:1186-1192.

11. Kanno S*, Lee PC*, Zhang Y, Ho C, Griffith BP, Shears LL, Billiar TR. Attenuation of myocardial ischemia/reperfusion injury by superinduction of inducible nitric oxide synthase. Circulation 2000;101:2742-2748. * Shared co-authorship.

12. Lee PC, Wang ZL, Mahidhara R, Qian S, Watkins SC, Griffith BP, Billiar TR, Shears LL. Inducible nitric oxide synthase attenuates acute cardiac rejection. Surgical Forum 2000;51:357-359.

13. Lee PC, Kibbe MR, Schuchert MJ, Stolz DB, Watkins SC, Griffith BP, Billiar TR, Shears LL. Nitric oxide induces angiogenesis and upregulates v3 integrin expression on endothelial cells. Microvascular Research 2000;60:269-280.

14. Kanno S, Lee PC, Dodd SJ, Williams M, Griffith BP, Ho C. A novel approach with magnetic resonance imaging used for the detection of lung allograft rejection. J Thorac Cardiovasc Surg 2000;120:923-934.

15. Lee PC, Mateo RB, Clarke MR, Brown ML, Carty SE. Parathyromatosis: a cause for recurrent hyperparathyroidism. Endocrine Practice 2001;7:189-192.

16. Vorp DA, Lee PC, Wang DHJ, Makaroun MS, Nemoto EM, Ogawa S, Webster MW. Association of intraluminal thrombus in abdominal aortic aneurysm with local hypoxia and wall weakening. J Vasc Surg 2001;34:291-299.

17. Kanno S, Wu YL, Lee PC, Dodd SJ, Williams M, Griffith BP, Ho C. Macrophage accumulation associated with rat cardiac allograft rejection detected by magnetic resonance imaging with ultrasmall superparamagnetic iron oxide particles. Circulation 2001;104:934-938.

18. Kanno S, Wu YL, Lee PC, Billiar TR, Ho C. Angiotensin-converting enzyme inhibitor preserves p21 and endothelial nitric oxide synthase expressions in Monocrotaline-induced pulmonary arterial hypertension in rats. Circulation 2001;104:945-950.

19. Port JL, Kent M, Korst RJ, Lee PC, Levin MA, Flieder D, Altorki NK.
Surgical resection for lung cancer in the octogenarian. Chest 2004; 126(3):733-8.

20. Korst RJ, Gold HT, Kent MS, Port JL, Lee PC, Altorki NK. Surveillance computed tomography after complete resection for non-small cell lung cancer: results and costs. Journal of Thoracic & Cardiovascular Surgery 2005;129:652-60.

21. Port JL, Korst RJ, Lee PC, Levin MA, Becker DE, Keresztes R, Altorki NK. Surgical resection for residual N2 disease after induction chemotherapy. Ann Thorac Surg 2005; 79:1686-1690.

22. Korst RJ, Port JL, Lee PC, Altorki NK. Intrathoracic manifestations of cervical anastomotic leaks after transthoracic esophagectomy for carcinoma. Ann Thorac Surg 2005; 80:1185-90.

23. Kent MS, Korn P, Port JL, Lee PC, Altorki NK, Korst RJ. Cost effectiveness of chest computed tomography after lung cancer resection: a decision analysis model. Ann Thorac Surg 2005; 80:1215-23.

24. Port JL, Andrade RS, Levin MA, Korst RJ, Lee PC, Becker DE, Altorki NK. Positron emission tomographic scanning in the diagnosis and staging of non-small cell lung cancer 2 cm in size or less. J Thorac Cardiovasc Surg 2005;130:1611-5.

25. Korst RJ, Kansler AL, Port JL, Lee PC, Karem Y, Altorki NK. Downstaging of T or N predicts long-term survival after preoperative chemotherapy and radical resection for esophageal carcinoma. Ann Thorac Surg 2006;82:480-4.

26. Korst RJ, Kansler AL, Port JL, Lee PC, Altorki NK. Accuracy of surveillance computed tomography in detecting recurrent or new primary lung cancer in patients with completely resected lung cancer. Ann Thorac Surg 2006;82:1009-15.

27. Lee PC, Korst RJ, Port JL, Kerem Y, Kansler A, Altorki NK. Long-term survival and recurrence in patients with resected non-small cell lung cancer 1 cm or less in size. J Thorac Cardiovasc Surg 2006;132(6):1382-88.

28. Kreisel D, Arora N, Weisenberg SA, Saqi A, Krupnick AS, MDa, Demetriades AM, Iakovou C, Conetta R, Lee PC. Tuberculosis presenting as an endobronchial mass. J Thorac Cardiovasc Surg 2007;133:582-584.

29. Port JL, Korst RJ, Lee PC, Kansler AL, Kerem Y, Altorki NK. Surgical resection for multifocal (T4) non-small cell lung cancer: Is the T4 designation valid? Ann Thorac Surg 2007; 83:397-401.

30. Kim AW, Korst RJ, Port JL, Altorki NK, Lee PC. Giant cavernous hemangioma of the distal esophagus treated with esophagectomy. J Thorac Cardiovasc Surg 2007; 133: 1665 - 1667.

31. Lee PC, Port JL, Korst RJ, Liss Y, Meherally DN, Altork NK. Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer. Ann Thorac Surg 2007: 84: 177-181.

32. Robinson DA, Lee, PC. Middle lobe syndrome: Case report and review of literature. Clin Pulm Med 2007;14:244-248.

33. Port JL, Lee PC, Korst RJ, Liss Y, Meherally D, Christos P, Mazumdar M, and Altorki NK. Positron emission tomographic scanning predicts survival after induction chemotherapy for esophageal carcinoma. Ann Thorac Surg 2007;84:393-400.

34. Huston JM, King H, Maresh A, Liska D, Port JL, Altorki NK, and Lee PC. Hernia of Morgagni: Case report. J Thorac Cardiovasc Surg 2008; 135: 212 - 213.


CHAPTERS & REVIEW ARTICLES

Lee PC, Shears LL, Billiar TR. Role of inducible nitric oxide synthase in transplant arteriosclerosis. Clin Exp Pharmacol Physiol 1999;26:1013-1015.

Kibbe MR*, Lee PC*, Billiar TR, Tzeng E. Nitric oxide synthase gene transfer. In: Ignarro LJ, editor. Nitric oxide: Biology and pathobiology. 1st ed. Academic Press 2000:503-524.

* Shared co-authorship.

INVITED LECTURES

1. Current surgical management of lung cancer. New York Hospital Queens. Pulmonary Grand Rounds. New York, New York, June 2003.

2. Current management of lung cancer. New York Hospital Queens. Medical Grand Rounds. New York, New York, September 2003.

3. Lung cancer. New York Queens Nan Shan Senior Citizen Center. New York, New York, December 2003.

4. Lung cancer. Live radio (1480AM) interview. New York, New York, January 2004.

5. Advances in thoracoscopic surgery. New York Hospital Queens. Medical Grand Rounds. New York, New York, January 2004.

6. Surgical management of achalasia. New York Hospital Queens. Gastroenterology Grand Rounds. New York, New York, January 2004.

7. Current management of esophageal cancer. Chinese American Medical Society Annual Scientific Meeting. New York, New York, October 2004.

8. Current directions in the screening and management of lung cancer. First New York Hospital Queens Lung Cancer Symposium. Program Chair. Lecture: Current surgical staging and management of lung cancer. Flushing, New York, October 2004.

9. Diagnosis and treatment of lung cancer. Live radio (1480AM) interview. New York, New York, November 2004.

10. Current management of esophageal cancer. New York Hospital Queens. Medical Grand Rounds. New York, New York, November 2004.

11. Advances in thoracoscopic surgery. Annual Clinic Day. The Nassau Surgical Society and Brooklyn & Long Island Chapter of the American College of Surgeons. Long Island, New York, December 2004.

12. Current surgical management of benign esophageal diseases. New York Hospital Queens. Medical Grand Rounds. New York, New York, September 2005.

13. Advances in diagnosis and treatment of early stage lung cancer. Second New York Hospital Queens Lung Cancer Symposium. Program Chair. Lecture: Surgical staging and management of early stage lung cancer. Flushing, New York, October 2005.

14. Current directions in screening and management of early stage lung cancer. Third New York Hospital Queens Lung Cancer Symposium. Program Chair. Lecture: Advances in surgical staging and management of early stage non-small cell lung cancer. Flushing, New York, November 2006.

15. Diagnosis and treatment of lung cancer. Live radio (1480AM) interview. New York, New York, November 2006.